Alacris Theranostics GmbH, Berlin, Germany.
Max Planck Institute for Molecular Genetics, Ihnestraße 63, 14195, Berlin, Germany.
Sci Rep. 2022 Apr 4;12(1):5618. doi: 10.1038/s41598-022-08934-2.
Our lives (and deaths) have by now been dominated for two years by COVID-19, a pandemic that has caused hundreds of millions of disease cases, millions of deaths, trillions in economic costs, and major restrictions on our freedom. Here we suggest a novel tool for controlling the COVID-19 pandemic. The key element is a method for a population-scale PCR-based testing, applied on a systematic and repeated basis. For this we have developed a low cost, highly sensitive virus-genome-based test. Using Germany as an example, we demonstrate by using a mathematical model, how useful this strategy could have been in controlling the pandemic. We show using real-world examples how this might be implemented on a mass scale and discuss the feasibility of this approach.
我们的生活(和死亡)现在已经被 COVID-19 主导了两年,这是一场大流行,导致了数亿例疾病、数百万人死亡、数万亿美元的经济成本,并对我们的自由造成了重大限制。在这里,我们提出了一种控制 COVID-19 大流行的新工具。关键要素是一种基于聚合酶链反应的大规模人群检测方法,系统且重复地应用。为此,我们开发了一种低成本、高灵敏度的基于病毒基因组的检测方法。我们以德国为例,使用数学模型演示了这种策略在控制大流行方面可能会有多么有用。我们通过实际例子展示了如何在大规模上实施这一策略,并讨论了这种方法的可行性。